The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Sign in to access this content
Sign InIn a move highlighting the growing expansion of AI technologies within the healthcare sector, Realbotix has announced a strategic partnership with Bloom to launch a humanoid robot pilot program in the United Kingdom. This project, highlighted by Onconetix as part of its ongoing acquisition of Realbotix LLC, aims to utilize robots to combat social isolation among the elderly in Northeast England. According to reports, the initiative seeks to establish Realbotix as an accredited supplier within the UK public sector marketplace.
This development comes as the social robotics market experiences significant growth, with industry estimates suggesting healthcare is one of the fastest-growing sectors for these technologies to address labor shortages and aging populations. Looking at peers, Intuition Robotics recently announced expanded distribution for its ElliQ robot in the US, reflecting an intense technological race in this field. The partnership with Bloom Procurement Services is a vital step for Realbotix to enter UK government supply chains, potentially providing a competitive edge over other European startups.
Operationally, investors are awaiting the completion of Onconetix’s acquisition of Realbotix to assess the full financial impact of these partnerships on the company's balance sheet. While updated price data for ONCO is currently unavailable, expansion into international markets serves as a positive catalyst. Regarding economic indicators, UK Nationwide Housing Prices showed a 2.2% annual growth as of July 1, 2026, suggesting a relatively stable economic environment in the British market targeted by the company’s new project.